Tahir Misbah 4
4 · IGM Biosciences, Inc. · Filed Jul 23, 2024
Insider Transaction Report
Form 4
Tahir Misbah
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-07-19+33,111→ 121,959 total - Award
Common Stock
2024-07-19+2,222→ 124,181 total - Disposition to Issuer
Stock Option (right to buy)
2024-07-19−40,000→ 0 totalExercise: $91.50Exp: 2031-02-19→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-07-19−55,000→ 0 totalExercise: $40.27Exp: 2030-02-05→ Common Stock (55,000 underlying)
Footnotes (3)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares.
- [F3]These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.